Eosinophilic Granulomatosis Treatment Market - Global Outlook and Forecast 2021-2027

April 2021 | 93 pages | ID: EB496125AD48EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Eosinophilic Granulomatosis Treatment in Global, including the following market information:

Global Eosinophilic Granulomatosis Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Eosinophilic Granulomatosis Treatment market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Eosinophilic Granulomatosis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Eosinophilic Granulomatosis Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Eosinophilic Granulomatosis Treatment Market Segment Percentages, By Type, 2020 (%)

• By Drug Type
• Mepolizumab
• Rituximab
• Benralizumab
• Omalizumab
• Methotrexate Sodium
• Others
• By Route of Administration
• Oral
• Intravenous
• Intramuscular

China Eosinophilic Granulomatosis Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Eosinophilic Granulomatosis Treatment Market Segment Percentages, By Application, 2020 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Eosinophilic Granulomatosis Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Eosinophilic Granulomatosis Treatment Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Eosinophilic Granulomatosis Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Eosinophilic Granulomatosis Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• AstraZeneca plc
• GlaxoSmithKline LLC
• Baxter Healthcare Corporation
• Genentech Inc
• Teva Pharmaceutical Industries Ltd
• Koninklijke DSM NV
• Novartis International AG
• Pharma Holdings

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Nerve Ablation Devices Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Nerve Ablation Devices Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NERVE ABLATION DEVICES OVERALL MARKET SIZE

2.1 Global Nerve Ablation Devices Market Size: 2021 VS 2027
2.2 Global Nerve Ablation Devices Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Nerve Ablation Devices Sales (Consumption): 2016-2027

3 COMPANY LANDSCAPE

3.1 Top Nerve Ablation Devices Players in Global Market
3.2 Top Global Nerve Ablation Devices Companies Ranked by Revenue
3.3 Global Nerve Ablation Devices Revenue by Companies
3.4 Global Nerve Ablation Devices Sales by Companies
3.5 Global Nerve Ablation Devices Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Nerve Ablation Devices Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Nerve Ablation Devices Product Type
3.8 Tier 1, Tier 2 and Tier 3 Nerve Ablation Devices Players in Global Market
  3.8.1 List of Global Tier 1 Nerve Ablation Devices Companies
  3.8.2 List of Global Tier 2 and Tier 3 Nerve Ablation Devices Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Nerve Ablation Devices Market Size Markets, 2021 & 2027
  4.1.2 Radiofrequency Nerve Ablation Devices
  4.1.3 Microwave Nerve Ablation Devices
  4.1.4 Thermosphere Nerve Ablation Devices
4.2 By Type - Global Nerve Ablation Devices Revenue & Forecasts
  4.2.1 By Type - Global Nerve Ablation Devices Revenue, 2016-2021
  4.2.2 By Type - Global Nerve Ablation Devices Revenue, 2022-2027
  4.2.3 By Type - Global Nerve Ablation Devices Revenue Market Share, 2016-2027
4.3 By Type - Global Nerve Ablation Devices Sales & Forecasts
  4.3.1 By Type - Global Nerve Ablation Devices Sales, 2016-2021
  4.3.2 By Type - Global Nerve Ablation Devices Sales, 2022-2027
  4.3.3 By Type - Global Nerve Ablation Devices Sales Market Share, 2016-2027
4.4 By Type - Global Nerve Ablation Devices Price (Manufacturers Selling Prices), 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Nerve Ablation Devices Market Size, 2021 & 2027
  5.1.2 Hospitals
  5.1.3 Ambulatory Surgical Center
  5.1.4 Specialty Clinics
  5.1.5 Others
5.2 By Application - Global Nerve Ablation Devices Revenue & Forecasts
  5.2.1 By Application - Global Nerve Ablation Devices Revenue, 2016-2021
  5.2.2 By Application - Global Nerve Ablation Devices Revenue, 2022-2027
  5.2.3 By Application - Global Nerve Ablation Devices Revenue Market Share, 2016-2027
5.3 By Application - Global Nerve Ablation Devices Sales & Forecasts
  5.3.1 By Application - Global Nerve Ablation Devices Sales, 2016-2021
  5.3.2 By Application - Global Nerve Ablation Devices Sales, 2022-2027
  5.3.3 By Application - Global Nerve Ablation Devices Sales Market Share, 2016-2027
5.4 By Application - Global Nerve Ablation Devices Price (Manufacturers Selling Prices), 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Nerve Ablation Devices Market Size, 2021 & 2027
6.2 By Region - Global Nerve Ablation Devices Revenue & Forecasts
  6.2.1 By Region - Global Nerve Ablation Devices Revenue, 2016-2021
  6.2.2 By Region - Global Nerve Ablation Devices Revenue, 2022-2027
  6.2.3 By Region - Global Nerve Ablation Devices Revenue Market Share, 2016-2027
6.3 By Region - Global Nerve Ablation Devices Sales & Forecasts
  6.3.1 By Region - Global Nerve Ablation Devices Sales, 2016-2021
  6.3.2 By Region - Global Nerve Ablation Devices Sales, 2022-2027
  6.3.3 By Region - Global Nerve Ablation Devices Sales Market Share, 2016-2027
6.4 North America
  6.4.1 By Country - North America Nerve Ablation Devices Revenue, 2016-2027
  6.4.2 By Country - North America Nerve Ablation Devices Sales, 2016-2027
  6.4.3 US Nerve Ablation Devices Market Size, 2016-2027
  6.4.4 Canada Nerve Ablation Devices Market Size, 2016-2027
  6.4.5 Mexico Nerve Ablation Devices Market Size, 2016-2027
6.5 Europe
  6.5.1 By Country - Europe Nerve Ablation Devices Revenue, 2016-2027
  6.5.2 By Country - Europe Nerve Ablation Devices Sales, 2016-2027
  6.5.3 Germany Nerve Ablation Devices Market Size, 2016-2027
  6.5.4 France Nerve Ablation Devices Market Size, 2016-2027
  6.5.5 U.K. Nerve Ablation Devices Market Size, 2016-2027
  6.5.6 Italy Nerve Ablation Devices Market Size, 2016-2027
  6.5.7 Russia Nerve Ablation Devices Market Size, 2016-2027
  6.5.8 Nordic Countries Nerve Ablation Devices Market Size, 2016-2027
  6.5.9 Benelux Nerve Ablation Devices Market Size, 2016-2027
6.6 Asia
  6.6.1 By Region - Asia Nerve Ablation Devices Revenue, 2016-2027
  6.6.2 By Region - Asia Nerve Ablation Devices Sales, 2016-2027
  6.6.3 China Nerve Ablation Devices Market Size, 2016-2027
  6.6.4 Japan Nerve Ablation Devices Market Size, 2016-2027
  6.6.5 South Korea Nerve Ablation Devices Market Size, 2016-2027
  6.6.6 Southeast Asia Nerve Ablation Devices Market Size, 2016-2027
  6.6.7 India Nerve Ablation Devices Market Size, 2016-2027
6.7 South America
  6.7.1 By Country - South America Nerve Ablation Devices Revenue, 2016-2027
  6.7.2 By Country - South America Nerve Ablation Devices Sales, 2016-2027
  6.7.3 Brazil Nerve Ablation Devices Market Size, 2016-2027
  6.7.4 Argentina Nerve Ablation Devices Market Size, 2016-2027
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Nerve Ablation Devices Revenue, 2016-2027
  6.8.2 By Country - Middle East & Africa Nerve Ablation Devices Sales, 2016-2027
  6.8.3 Turkey Nerve Ablation Devices Market Size, 2016-2027
  6.8.4 Israel Nerve Ablation Devices Market Size, 2016-2027
  6.8.5 Saudi Arabia Nerve Ablation Devices Market Size, 2016-2027
  6.8.6 UAE Nerve Ablation Devices Market Size, 2016-2027

7 MANUFACTURERS & BRANDS PROFILES

7.1 Medtronic
  7.1.1 Medtronic Corporate Summary
  7.1.2 Medtronic Business Overview
  7.1.3 Medtronic Nerve Ablation Devices Major Product Offerings
  7.1.4 Medtronic Nerve Ablation Devices Sales and Revenue in Global (2016-2021)
  7.1.5 Medtronic Key News
7.2 Boston Scientific Corporation
  7.2.1 Boston Scientific Corporation Corporate Summary
  7.2.2 Boston Scientific Corporation Business Overview
  7.2.3 Boston Scientific Corporation Nerve Ablation Devices Major Product Offerings
  7.2.4 Boston Scientific Corporation Nerve Ablation Devices Sales and Revenue in Global (2016-2021)
  7.2.5 Boston Scientific Corporation Key News
7.3 Abbott
  7.3.1 Abbott Corporate Summary
  7.3.2 Abbott Business Overview
  7.3.3 Abbott Nerve Ablation Devices Major Product Offerings
  7.3.4 Abbott Nerve Ablation Devices Sales and Revenue in Global (2016-2021)
  7.3.5 Abbott Key News
7.4 AtriCure, Inc
  7.4.1 AtriCure, Inc Corporate Summary
  7.4.2 AtriCure, Inc Business Overview
  7.4.3 AtriCure, Inc Nerve Ablation Devices Major Product Offerings
  7.4.4 AtriCure, Inc Nerve Ablation Devices Sales and Revenue in Global (2016-2021)
  7.4.5 AtriCure, Inc Key News
7.5 AngioDynamics
  7.5.1 AngioDynamics Corporate Summary
  7.5.2 AngioDynamics Business Overview
  7.5.3 AngioDynamics Nerve Ablation Devices Major Product Offerings
  7.5.4 AngioDynamics Nerve Ablation Devices Sales and Revenue in Global (2016-2021)
  7.5.5 AngioDynamics Key News
7.6 Stryker
  7.6.1 Stryker Corporate Summary
  7.6.2 Stryker Business Overview
  7.6.3 Stryker Nerve Ablation Devices Major Product Offerings
  7.6.4 Stryker Nerve Ablation Devices Sales and Revenue in Global (2016-2021)
  7.6.5 Stryker Key News
7.7 Halyard Health, Inc
  7.7.1 Halyard Health, Inc Corporate Summary
  7.7.2 Halyard Health, Inc Business Overview
  7.7.3 Halyard Health, Inc Nerve Ablation Devices Major Product Offerings
  7.4.4 Halyard Health, Inc Nerve Ablation Devices Sales and Revenue in Global (2016-2021)
  7.7.5 Halyard Health, Inc Key News

8 GLOBAL NERVE ABLATION DEVICES PRODUCTION CAPACITY, ANALYSIS

8.1 Global Nerve Ablation Devices Production Capacity, 2016-2027
8.2 Nerve Ablation Devices Production Capacity of Key Manufacturers in Global Market
8.3 Global Nerve Ablation Devices Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 NERVE ABLATION DEVICES SUPPLY CHAIN ANALYSIS

10.1 Nerve Ablation Devices Industry Value Chain
10.2 Nerve Ablation Devices Upstream Market
10.3 Nerve Ablation Devices Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Nerve Ablation Devices Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Eosinophilic Granulomatosis Treatment Market Opportunities & Trends in Global Market
Table 2. Eosinophilic Granulomatosis Treatment Market Drivers in Global Market
Table 3. Eosinophilic Granulomatosis Treatment Market Restraints in Global Market
Table 4. Key Players of Eosinophilic Granulomatosis Treatment in Global Market
Table 5. Top Eosinophilic Granulomatosis Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Eosinophilic Granulomatosis Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Eosinophilic Granulomatosis Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Eosinophilic Granulomatosis Treatment Product Type
Table 9. List of Global Tier 1 Eosinophilic Granulomatosis Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Eosinophilic Granulomatosis Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Eosinophilic Granulomatosis Treatment Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Eosinophilic Granulomatosis Treatment Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Eosinophilic Granulomatosis Treatment Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Eosinophilic Granulomatosis Treatment Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Eosinophilic Granulomatosis Treatment Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Eosinophilic Granulomatosis Treatment Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2022-2027
Table 30. AstraZeneca plc Corporate Summary
Table 31. AstraZeneca plc Eosinophilic Granulomatosis Treatment Product Offerings
Table 32. AstraZeneca plc Eosinophilic Granulomatosis Treatment Revenue (US$, Mn), (2016-2021)
Table 33. GlaxoSmithKline LLC Corporate Summary
Table 34. GlaxoSmithKline LLC Eosinophilic Granulomatosis Treatment Product Offerings
Table 35. GlaxoSmithKline LLC Eosinophilic Granulomatosis Treatment Revenue (US$, Mn), (2016-2021)
Table 36. Baxter Healthcare Corporation Corporate Summary
Table 37. Baxter Healthcare Corporation Eosinophilic Granulomatosis Treatment Product Offerings
Table 38. Baxter Healthcare Corporation Eosinophilic Granulomatosis Treatment Revenue (US$, Mn), (2016-2021)
Table 39. Genentech Inc Corporate Summary
Table 40. Genentech Inc Eosinophilic Granulomatosis Treatment Product Offerings
Table 41. Genentech Inc Eosinophilic Granulomatosis Treatment Revenue (US$, Mn), (2016-2021)
Table 42. Teva Pharmaceutical Industries Ltd Corporate Summary
Table 43. Teva Pharmaceutical Industries Ltd Eosinophilic Granulomatosis Treatment Product Offerings
Table 44. Teva Pharmaceutical Industries Ltd Eosinophilic Granulomatosis Treatment Revenue (US$, Mn), (2016-2021)
Table 45. Koninklijke DSM NV Corporate Summary
Table 46. Koninklijke DSM NV Eosinophilic Granulomatosis Treatment Product Offerings
Table 47. Koninklijke DSM NV Eosinophilic Granulomatosis Treatment Revenue (US$, Mn), (2016-2021)
Table 48. Novartis International AG Corporate Summary
Table 49. Novartis International AG Eosinophilic Granulomatosis Treatment Product Offerings
Table 50. Novartis International AG Eosinophilic Granulomatosis Treatment Revenue (US$, Mn), (2016-2021)
Table 51. Pharma Holdings Corporate Summary
Table 52. Pharma Holdings Eosinophilic Granulomatosis Treatment Product Offerings
Table 53. Pharma Holdings Eosinophilic Granulomatosis Treatment Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Eosinophilic Granulomatosis Treatment Segment by Type
Figure 2. Eosinophilic Granulomatosis Treatment Segment by Application
Figure 3. Global Eosinophilic Granulomatosis Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Eosinophilic Granulomatosis Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Eosinophilic Granulomatosis Treatment Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Eosinophilic Granulomatosis Treatment Revenue in 2020
Figure 8. By Type - Global Eosinophilic Granulomatosis Treatment Revenue Market Share, 2016-2027
Figure 9. By Application - Global Eosinophilic Granulomatosis Treatment Revenue Market Share, 2016-2027
Figure 10. By Region - Global Eosinophilic Granulomatosis Treatment Revenue Market Share, 2016-2027
Figure 11. By Country - North America Eosinophilic Granulomatosis Treatment Revenue Market Share, 2016-2027
Figure 12. US Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Eosinophilic Granulomatosis Treatment Revenue Market Share, 2016-2027
Figure 16. Germany Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2016-2027
Figure 17. France Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Eosinophilic Granulomatosis Treatment Revenue Market Share, 2016-2027
Figure 24. China Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2016-2027
Figure 28. India Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Eosinophilic Granulomatosis Treatment Revenue Market Share, 2016-2027
Figure 30. Brazil Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Eosinophilic Granulomatosis Treatment Revenue Market Share, 2016-2027
Figure 33. Turkey Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Eosinophilic Granulomatosis Treatment Revenue, (US$, Mn), 2016-2027
Figure 37. AstraZeneca plc Eosinophilic Granulomatosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. GlaxoSmithKline LLC Eosinophilic Granulomatosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Baxter Healthcare Corporation Eosinophilic Granulomatosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Genentech Inc Eosinophilic Granulomatosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Teva Pharmaceutical Industries Ltd Eosinophilic Granulomatosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Koninklijke DSM NV Eosinophilic Granulomatosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Novartis International AG Eosinophilic Granulomatosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)